You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Express Scripts

Last Updated: July 13, 2020

DrugPatentWatch Database Preview

Drugs in Development Information for Fluoride ion

Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

What is the development status for investigational drug Fluoride ion?

Fluoride ion is an investigational drug.

There have been 5 clinical trials for Fluoride ion. The most recent clinical trial was a Phase 1 trial, which was initiated on September 15th 2017.

The most common disease conditions in clinical trials are Dental Caries, Tooth Demineralization, and [disabled in preview]. The leading clinical trial sponsors are University of Campinas, Brazil, The University of Hong Kong, and University of Iowa.

There are seventy-eight US patents protecting this investigational drug and one international patent.

Recent Clinical Trials for Fluoride ion
Prospective Randomized Controlled Trial for Prevention of Demineralization During Fixed Orthodontic TreatmentThe University of Hong KongPhase 2
Silver Diamine Fluoride Pilot Study (SDF)University of IowaPhase 0
Long-term Release of Fluoride Formed on Enamel by Fluoride Gel or Varnish to Biofilm FluidUniversity of Campinas, BrazilPhase 0

See all Fluoride ion clinical trials

Clinical Trial Summary for Fluoride ion

Top disease conditions for Fluoride ion
Top clinical trial sponsors for Fluoride ion

See all Fluoride ion clinical trials

US Patents for Fluoride ion

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Fluoride ion   Start Trial Processes for coated carrier particles Xerox Corporation (Stamford, CT)   Start Trial
Fluoride ion   Start Trial Process for the preparation of difluoromaleic anhydride E. I. Du Pont de Nemours and Company (Wilmington, DE)   Start Trial
Fluoride ion   Start Trial Herbicidal oxabicycloalkane ethers E.I. Du Pont de Nemours and Company (Wilmington, DE)   Start Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.